SCHEMBL8790755

SCHEMBL8790755

COc1ccc2[nH]c3c(C(=O)Nc4ccc(CCCCN(C)CCc5ccc(OC)c(OC)c5)cc4)cccc3c(=O)c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 5/20 0.58
▸ ABCB1 P08183 3/20 0.49
▸ MAPT P10636 4/20 0.48
▸ LMNA P02545 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ TP53 P04637 3/20 0.43
▸ CYP3A4 P08684 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ DHODH Q02127 1/20 0.41
▸ SMPD1 P17405 1/20 0.40
▸ PARP14 Q460N5 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C8 P10632 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789898 0.94 ABCG2 (0.56) ABCG2ABCB1MAPTLMNAALDH1A1
SCHEMBL8789962 0.92 ABCG2 (0.65) ABCG2ABCB1MAPTLMNAALDH1A1
SCHEMBL8789246 0.90 ABCG2 (0.66) ABCG2ABCB1MAPTLMNATP53
SCHEMBL8790105 0.89 ABCG2 (0.61) ABCG2ABCB1MAPTALDH1A1TP53
SCHEMBL8789562 0.89 ABCG2 (0.69) ABCG2ABCB1MAPTLMNATP53
SCHEMBL8789166 0.88 ABCG2 (0.65) ABCG2ABCB1MAPTTP53KDM4E
SCHEMBL8790216 0.87 ABCG2 (0.62) ABCG2ABCB1MAPTLMNAALDH1A1
SCHEMBL8789989 0.86 ABCG2 (0.63) ABCG2ABCB1MAPTLMNATP53
SCHEMBL8835984 0.86 ABCG2 (0.58) ABCG2ABCB1MAPTTP53MEN1
SCHEMBL8789662 0.86 ABCG2 (0.64) ABCG2ABCB1MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP disclosed
Send feedback